Innovative therapeutics with a de-risked approach
PurMinds owns and operates a portfolio of synergistic technical assets and special licenses that give the Company a competitive edge with multiple paths towards revenue goal. In addition to creating long-term value through innovating best-in-class therapeutics with proven mechanisms of action and next generation therapeutics, PurMinds is developing revenue programs including our own proprietary botanical psilocybin formulation for global supply.
PurMinds operates out of the PurMinds NeuroLabs in Ontario, Canada with a Health Canada approved Controlled Drugs and Substance License.
​
TM
Our People
With strong management, scientific and business backgrounds, our team is committed to developing best-in-class disease-modifying therapeutics and next generation pre-emptive intervention for neurological conditions. Collectively, we work to develop novel solutions that address underlying pathologies associated with a variety of CNS disorders. Ultimately, our goal is to revolutionize patient outcomes and enhance their quality of life.
Our Team
Founder,
President & Chief Executive Officer
A serial entrepreneur and strategic visionary with 15+ years of corporate banking experience and 8+ years of strategic management and business development work in investment, biotech and branding marketing field.
Chief Financial Officer &
Chief Operating Officer
Senior Financial Leader with 30+ years experience in FP&A, Business Valuation, general accounting, risk management, and in driving financial and operational excellence.
Vice President, NeuroLabs
Over 25 years of experience in laboratory operation and management, scientific research team leadership in chemistry, multi-omics for biomarker based precision medicine.
Vice President,
ADMPK & Pharmacology
Experienced team leader with 20+ years of track records in drug absorption, distribution, metabolism, excretion, pharmacokinetics and pharmacology. Dr. Duan is part of the success exit story of Inversago Pharma as their Executive VP, Pharmacology/DMPK.
Vice President, Technology
Strong science background with extensive experience in research and development for laboratory and production technology. Ms. Kim plays a key role in the advancement of PurMinds botanical production process, and is desired to support the development of new therapies for devastating neurological diseases.
Clinical Investigator
Co-Principal Investigator of Psychedelic clinical trials and adjunct teaching faculty in Johns Hopkins University.
Director, Quality and
Regulatory Affairs​
With extensive experience and a long track-record in quality assurance and regulatory affairs, Mr. Wallace is helping Purminds navigate the regulatory framework of Health Canada, the US FDA and the European Medicines Agency (EMA).
Scientific Advisory Board
​
Professor
Professor of Radiation Oncology
Mayo Clinic, Rochester
​​
Extensive research on radiation, Psychology, and clinical interventional oncology; first MD in Mayo certified to provide Psychedelic-assisted therapy to patients.
Sheng-Tao Hou, Ph.D.
​
Professor of Neurobiology
Director,
Brain Research Center
Southern University of Science and Technology (SUSTech)
Adjunct Professor
University of Ottawa Health Services
Honorary Professor
Queensland Brain Institute
The University of Queensland (UQ)
Executive Director,
SUSTech-UQ Joint Center for Neuroscience & Neural Engineering
Mathieu Miron, Ph.D.
​
Partner &
Patent Agent,
registered to act before the Canadian and United States Patent Offices, with specialties in biochemistry, organic chemistry, biotechnology, pharmaceutical inventions, food science, medical devices, simple mechanics and business methods
BENOÎT & CÔTÉ,
​
Stacy D’Andre, M.D.
Associate Professor, Oncologist
Mayo Clinic, Rochester
Board-certified medial oncologist with formal training in Psychology, founder of Integrative Oncology Clinic at Mayo Clinic
Maria Lapid, M.D.
Founding Program Director of
Geriatric Psychiatry Fellowship
Mayo Clinic, Rochester
Specialist in palliative approach for psychogeriatric patients with dementia and cancer